Dr. Glassman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Morris Ave
#326
Long Branch, NJ 07740
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1991 - 1994
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1987 - 1990
- Harvard Medical SchoolClass of 1987
Certifications & Licensure
- NY State Medical License 1990 - 2026
- PA State Medical License 1988 - 1990
Publications & Presentations
PubMed
- 7 citationsWhen are results of single-arm studies dramatic?Robert H. Glassman, Grace Kim, Marc J. Kahn
Nature Reviews. Clinical Oncology. 2020-11-01 - 55 citationsDoxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.Paul A. Yates, Steven A. Newman, Lauren Oshry, Robert H. Glassman, Ashton M. Leone
Therapeutic Advances in Respiratory Disease. 2020-09-01 - 16 citationsBiomarkers in early cancer drug development: limited utility.Robert H. Glassman, Mark J. Ratain
Clinical Pharmacology and Therapeutics. 2009-02-01
Journal Articles
- New Cures Require New Pricing PoliciesRena Conti, Robert Glassman, and Mark Ratain, Health Affairs, 4/16/2015
Press Mentions
- Jubilant Therapeutics Appoints Dr. Robert Glassman to Its Board of DirectorsFebruary 5th, 2021
- Tarus Therapeutics Strengthens Its Board of Directors with Appointments of Mark Cohen and Robert GlassmanNovember 19th, 2020
Research History
- Postdoctoral FellowLaboratory of Hidesaburo Hanafusa1991 - 1996
Professional Memberships
- Member
- Member
- Member
- AACRMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: